Are you Dr. Wholey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
320 E North Ave
Pittsburgh, PA 15212Phone+1 412-359-8820Fax+1 412-359-8222
Summary
- Dr. Mark Wholey, MD is an Interventional Radiologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Florida, and Minnesota.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiology-Diagnostic, 1955 - 1958
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Radiology-Diagnostic, 1954 - 1955
UPMC Medical Education (Mercy)Internship, Transitional Year, 1953 - 1954
Drexel University College of MedicineClass of 1953- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Vascular and Interventional Radiology
Certifications & Licensure
PA State Medical License 1954 - 2022
FL State Medical License 1973 - 1985
MN State Medical License 1956 - 1959- American Board of Radiology Radiology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FSIR) Society of Interventional Radiology
Clinical Trials
- ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial" Start of enrollment: 2000 May 01
- CAPTURE 2 Post-Marketing Registry Start of enrollment: 2006 Mar 01
Publications & Presentations
PubMed
- 2 citationsEndovascular Therapy for Acute Ischemic Stroke: A Comprehensive Review of Current Status.Ismail Dogu Kilic, Abdul Hakeem, Konstantinos Marmagkiolis, Andre R.M. Paixao, Iris Q. Grunwald
Cardiovascular Revascularization Medicine. 2019-05-01 - 3 citationsDirect carotid access for endovascular management of acute ischaemic stroke.Mehmet Cilingiroglu, Abdul Hakeem, Mark H. Wholey, Omer Goktekin
Eurointervention. 2017-10-01 - 2 citationsFirst Clinical Experience With Targeted REnal Nerve Demodulation (TREND-1) Using a Neurotropic Agent for the Treatment of Sympathetic Hypertension.Nicholas Kipshidze, Horst Sievert, Michael H. Wholey, Konstantin Kipiani, Vakhtang Kipiani
The Journal of Invasive Cardiology. 2017-01-15
Press Mentions
Press RoomSeptember 17th, 2015
Interventional News: Evolving EcosystemsAugust 4th, 2018
Professional Memberships
- Fellow
